STOCK TITAN

[NPORT-P] iShares Trust iShares USD Systematic Bond ETF SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
NPORT-P
Rhea-AI Filing Summary

Form NPORT-P filing for iShares Trust – iShares USD Systematic Bond ETF (ticker: USBF) contains no substantive portfolio or financial data. All key sections – assets & liabilities, risk metrics, securities-lending details, returns, and derivatives disclosures – are blank. The registrant, series, LEI, address, and contact fields are also left empty. Only the boiler-plate structure of the monthly portfolio report is present and the filing is marked as a LIVE electronic submission.

Because the quantitative schedules are not populated, investors receive no insight into USBF’s net assets, portfolio composition, risk exposure, or recent performance from this document. There is likewise no indication that the Fund considers this its final NPORT-P filing.

Overall, the submission appears to be an incomplete or placeholder filing, offering minimal information beyond confirming the ETF’s regulatory obligation to file monthly reports.

La presentazione del modulo NPORT-P per iShares Trust – iShares USD Systematic Bond ETF (ticker: USBF) non contiene dati sostanziali sul portafoglio o informazioni finanziarie. Tutte le sezioni principali – attività e passività, metriche di rischio, dettagli sul prestito titoli, rendimenti e informazioni sui derivati – risultano vuote. Anche i campi relativi al registrante, serie, LEI, indirizzo e contatti sono lasciati in bianco. È presente solo la struttura standard del rapporto mensile sul portafoglio e la presentazione è contrassegnata come una sottomissione elettronica LIVE.

Poiché i programmi quantitativi non sono compilati, gli investitori non ottengono alcuna informazione sul patrimonio netto di USBF, la composizione del portafoglio, l'esposizione al rischio o le prestazioni recenti da questo documento. Non vi è nemmeno alcuna indicazione che il Fondo consideri questa la sua presentazione finale del modulo NPORT-P.

In generale, la sottomissione sembra essere una presentazione incompleta o provvisoria, che fornisce informazioni minime oltre a confermare l'obbligo normativo dell'ETF di presentare rapporti mensili.

La presentación del formulario NPORT-P para iShares Trust – iShares USD Systematic Bond ETF (símbolo: USBF) no contiene datos sustantivos sobre la cartera ni información financiera. Todas las secciones clave – activos y pasivos, métricas de riesgo, detalles sobre préstamos de valores, rendimientos y divulgaciones de derivados – están en blanco. Los campos de registrante, serie, LEI, dirección y contacto también están vacíos. Solo está presente la estructura estándar del informe mensual de cartera y la presentación está marcada como una sumisión electrónica en VIVO.

Dado que los horarios cuantitativos no están completados, los inversores no reciben ninguna información sobre los activos netos de USBF, la composición de la cartera, la exposición al riesgo o el rendimiento reciente a partir de este documento. Tampoco hay indicios de que el Fondo considere esta su presentación final del formulario NPORT-P.

En general, la presentación parece ser una presentación incompleta o provisional, que ofrece información mínima más allá de confirmar la obligación regulatoria del ETF de presentar informes mensuales.

iShares Trust – iShares USD Systematic Bond ETF(티커: USBF)의 NPORT-P 서류 제출에는 실질적인 포트폴리오나 재무 데이터가 포함되어 있지 않습니다. 자산 및 부채, 위험 지표, 증권 대여 세부사항, 수익률, 파생상품 공시 등 주요 섹션이 모두 비어 있습니다. 등록자, 시리즈, LEI, 주소 및 연락처 필드도 빈 상태로 남아 있습니다. 월간 포트폴리오 보고서의 기본 구조만 존재하며, 제출은 LIVE 전자 제출로 표시되어 있습니다.

정량적 일정이 채워지지 않아 투자자들은 이 문서로부터 USBF의 순자산, 포트폴리오 구성, 위험 노출 또는 최근 성과에 대한 어떠한 정보도 얻을 수 없습니다. 또한 펀드가 이를 최종 NPORT-P 제출로 간주한다는 표시도 없습니다.

전반적으로, 이 제출은 불완전하거나 임시 제출물로 보이며, ETF가 월간 보고서를 제출해야 하는 규제 의무만을 확인하는 최소한의 정보만 제공합니다.

Le dépôt du formulaire NPORT-P pour iShares Trust – iShares USD Systematic Bond ETF (symbole : USBF) ne contient aucune donnée substantielle sur le portefeuille ou les informations financières. Toutes les sections clés – actifs et passifs, mesures de risque, détails sur le prêt de titres, rendements et divulgations sur les dérivés – sont vides. Les champs concernant le déposant, la série, le LEI, l'adresse et les contacts sont également laissés vides. Seule la structure standard du rapport mensuel de portefeuille est présente et le dépôt est marqué comme une soumission électronique LIVE.

Comme les tableaux quantitatifs ne sont pas remplis, les investisseurs ne reçoivent aucune information sur les actifs nets de USBF, la composition du portefeuille, l'exposition au risque ou la performance récente à partir de ce document. Il n'y a pas non plus d'indication que le Fonds considère ce dépôt comme son dernier NPORT-P.

Dans l'ensemble, la soumission semble être un dépôt incomplet ou provisoire, offrant des informations minimales au-delà de la confirmation de l'obligation réglementaire de l'ETF de déposer des rapports mensuels.

Die NPORT-P-Einreichung für iShares Trust – iShares USD Systematic Bond ETF (Ticker: USBF) enthält keine wesentlichen Portfolio- oder Finanzdaten. Alle wichtigen Abschnitte – Vermögenswerte & Verbindlichkeiten, Risikokennzahlen, Details zur Wertpapierleihe, Renditen und Derivateoffenlegungen – sind leer. Auch die Felder für den Registranten, Serie, LEI, Adresse und Kontakt sind unbesetzt. Es ist nur die Standardstruktur des monatlichen Portfolioberichts vorhanden, und die Einreichung ist als LIVE elektronische Übermittlung gekennzeichnet.

Da die quantitativen Zeitpläne nicht ausgefüllt sind, erhalten Investoren aus diesem Dokument keine Einblicke in USBFs Nettovermögen, Portfoliostruktur, Risikoexposition oder jüngste Performance. Ebenso gibt es keinen Hinweis darauf, dass der Fonds dies als seine endgültige NPORT-P-Einreichung betrachtet.

Insgesamt scheint die Einreichung eine unvollständige oder Platzhalter-Einreichung zu sein, die nur minimale Informationen bietet und lediglich die regulatorische Verpflichtung des ETFs zur monatlichen Berichterstattung bestätigt.

Positive
  • None.
Negative
  • No financial metrics disclosed, preventing assessment of USBF's portfolio, risk profile, or performance.
  • Key registrant and series identifiers missing, limiting transparency for investors.

Insights

TL;DR: Filing is blank; no portfolio or performance data, therefore little investor impact.

This NPORT-P for iShares USD Systematic Bond ETF provides only the form’s template without quantitative disclosures. The absence of assets, liabilities, risk metrics and return data means investors cannot evaluate NAV, duration, credit profile or recent performance. While the LIVE status confirms regulatory submission, the lack of substance renders the document immaterial for valuation or risk assessment. Unless a corrected filing follows, the market impact is negligible.

La presentazione del modulo NPORT-P per iShares Trust – iShares USD Systematic Bond ETF (ticker: USBF) non contiene dati sostanziali sul portafoglio o informazioni finanziarie. Tutte le sezioni principali – attività e passività, metriche di rischio, dettagli sul prestito titoli, rendimenti e informazioni sui derivati – risultano vuote. Anche i campi relativi al registrante, serie, LEI, indirizzo e contatti sono lasciati in bianco. È presente solo la struttura standard del rapporto mensile sul portafoglio e la presentazione è contrassegnata come una sottomissione elettronica LIVE.

Poiché i programmi quantitativi non sono compilati, gli investitori non ottengono alcuna informazione sul patrimonio netto di USBF, la composizione del portafoglio, l'esposizione al rischio o le prestazioni recenti da questo documento. Non vi è nemmeno alcuna indicazione che il Fondo consideri questa la sua presentazione finale del modulo NPORT-P.

In generale, la sottomissione sembra essere una presentazione incompleta o provvisoria, che fornisce informazioni minime oltre a confermare l'obbligo normativo dell'ETF di presentare rapporti mensili.

La presentación del formulario NPORT-P para iShares Trust – iShares USD Systematic Bond ETF (símbolo: USBF) no contiene datos sustantivos sobre la cartera ni información financiera. Todas las secciones clave – activos y pasivos, métricas de riesgo, detalles sobre préstamos de valores, rendimientos y divulgaciones de derivados – están en blanco. Los campos de registrante, serie, LEI, dirección y contacto también están vacíos. Solo está presente la estructura estándar del informe mensual de cartera y la presentación está marcada como una sumisión electrónica en VIVO.

Dado que los horarios cuantitativos no están completados, los inversores no reciben ninguna información sobre los activos netos de USBF, la composición de la cartera, la exposición al riesgo o el rendimiento reciente a partir de este documento. Tampoco hay indicios de que el Fondo considere esta su presentación final del formulario NPORT-P.

En general, la presentación parece ser una presentación incompleta o provisional, que ofrece información mínima más allá de confirmar la obligación regulatoria del ETF de presentar informes mensuales.

iShares Trust – iShares USD Systematic Bond ETF(티커: USBF)의 NPORT-P 서류 제출에는 실질적인 포트폴리오나 재무 데이터가 포함되어 있지 않습니다. 자산 및 부채, 위험 지표, 증권 대여 세부사항, 수익률, 파생상품 공시 등 주요 섹션이 모두 비어 있습니다. 등록자, 시리즈, LEI, 주소 및 연락처 필드도 빈 상태로 남아 있습니다. 월간 포트폴리오 보고서의 기본 구조만 존재하며, 제출은 LIVE 전자 제출로 표시되어 있습니다.

정량적 일정이 채워지지 않아 투자자들은 이 문서로부터 USBF의 순자산, 포트폴리오 구성, 위험 노출 또는 최근 성과에 대한 어떠한 정보도 얻을 수 없습니다. 또한 펀드가 이를 최종 NPORT-P 제출로 간주한다는 표시도 없습니다.

전반적으로, 이 제출은 불완전하거나 임시 제출물로 보이며, ETF가 월간 보고서를 제출해야 하는 규제 의무만을 확인하는 최소한의 정보만 제공합니다.

Le dépôt du formulaire NPORT-P pour iShares Trust – iShares USD Systematic Bond ETF (symbole : USBF) ne contient aucune donnée substantielle sur le portefeuille ou les informations financières. Toutes les sections clés – actifs et passifs, mesures de risque, détails sur le prêt de titres, rendements et divulgations sur les dérivés – sont vides. Les champs concernant le déposant, la série, le LEI, l'adresse et les contacts sont également laissés vides. Seule la structure standard du rapport mensuel de portefeuille est présente et le dépôt est marqué comme une soumission électronique LIVE.

Comme les tableaux quantitatifs ne sont pas remplis, les investisseurs ne reçoivent aucune information sur les actifs nets de USBF, la composition du portefeuille, l'exposition au risque ou la performance récente à partir de ce document. Il n'y a pas non plus d'indication que le Fonds considère ce dépôt comme son dernier NPORT-P.

Dans l'ensemble, la soumission semble être un dépôt incomplet ou provisoire, offrant des informations minimales au-delà de la confirmation de l'obligation réglementaire de l'ETF de déposer des rapports mensuels.

Die NPORT-P-Einreichung für iShares Trust – iShares USD Systematic Bond ETF (Ticker: USBF) enthält keine wesentlichen Portfolio- oder Finanzdaten. Alle wichtigen Abschnitte – Vermögenswerte & Verbindlichkeiten, Risikokennzahlen, Details zur Wertpapierleihe, Renditen und Derivateoffenlegungen – sind leer. Auch die Felder für den Registranten, Serie, LEI, Adresse und Kontakt sind unbesetzt. Es ist nur die Standardstruktur des monatlichen Portfolioberichts vorhanden, und die Einreichung ist als LIVE elektronische Übermittlung gekennzeichnet.

Da die quantitativen Zeitpläne nicht ausgefüllt sind, erhalten Investoren aus diesem Dokument keine Einblicke in USBFs Nettovermögen, Portfoliostruktur, Risikoexposition oder jüngste Performance. Ebenso gibt es keinen Hinweis darauf, dass der Fonds dies als seine endgültige NPORT-P-Einreichung betrachtet.

Insgesamt scheint die Einreichung eine unvollständige oder Platzhalter-Einreichung zu sein, die nur minimale Informationen bietet und lediglich die regulatorische Verpflichtung des ETFs zur monatlichen Berichterstattung bestätigt.

NPORT-P: Filer Information

Filer CIK
Filer CCC
Filer Investment Company Type
Is this a LIVE or TEST Filing? LIVE TEST
Would you like a Return Copy?
Is this an electronic copy of an official filing submitted in paper format?

Submission Contact Information

Name
Phone
E-Mail Address

Notification Information

Notify via Filing Website only?
Series ID
Class (Contract) ID

NPORT-P: Part A: General Information

Item A.1. Information about the Registrant.

a. Name of Registrant
b. Investment Company Act file number for Registrant: (e.g., 811-______)
c. CIK number of Registrant
d. LEI of Registrant

e. Address and telephone number of Registrant.
Street Address 1
Street Address 2
City
State, if applicable
Foreign country, if applicable
Zip / Postal Code
Telephone number

Item A.2. Information about the Series.

a. Name of Series.
b. EDGAR series identifier (if any).
c. LEI of Series.

Item A.3. Reporting period.

a. Date of fiscal year-end.
b. Date as of which information is reported.

Item A.4. Final filing

Does the Fund anticipate that this will be its final filing on Form N PORT? Yes No

NPORT-P: Part B: Information About the Fund

Report the following information for the Fund and its consolidated subsidiaries.

Item B.1. Assets and liabilities. Report amounts in U.S. dollars.

a. Total assets, including assets attributable to miscellaneous securities reported in Part D.
b. Total liabilities.
c. Net assets.

Item B.2. Certain assets and liabilities. Report amounts in U.S. dollars.

a. Assets attributable to miscellaneous securities reported in Part D.
b. Assets invested in a Controlled Foreign Corporation for the purpose of investing in certain types of instruments such as, but not limited to, commodities.

c. Borrowings attributable to amounts payable for notes payable, bonds, and similar debt, as reported pursuant to rule 6-04(13)(a) of Regulation S-X [17 CFR 210.6-04(13)(a)].

Amounts payable within one year.
Banks or other financial institutions for borrowings.
Controlled companies.
Other affiliates.
Others.
Amounts payable after one year.
Banks or other financial institutions for borrowings.
Controlled companies.
Other affiliates.
Others.

d. Payables for investments purchased either (i) on a delayed delivery, when-issued, or other firm commitment basis, or (ii) on a standby commitment basis.

(i) On a delayed delivery, when-issued, or other firm commitment basis:
(ii) On a standby commitment basis:
e. Liquidation preference of outstanding preferred stock issued by the Fund.
f. Cash and cash equivalents not reported in Parts C and D.

Item B.3. Portfolio level risk metrics.

If the average value of the Fund's debt securities positions for the previous three months, in the aggregate, exceeds 25% or more of the Fund's net asset value, provide:

Currency Metric: 1
ISO Currency code

a. Interest Rate Risk (DV01). For each currency for which the Fund had a value of 1% or more of the Fund's net asset value, provide the change in value of the portfolio resulting from a 1 basis point change in interest rates, for each of the following maturities: 3 month, 1 year, 5 years, 10 years, and 30 years.

Maturity period.
3 month.
1 year.
5 years.
10 years.
30 years.

b. Interest Rate Risk (DV100). For each currency for which the Fund had a value of 1% or more of the Fund's net asset value, provide the change in value of the portfolio resulting from a 100 basis point change in interest rates, for each of the following maturities: 3 month, 1 year, 5 years, 10 years, and 30 years.

Maturity period.
3 month.
1 year.
5 years.
10 years.
30 years.

c. Credit Spread Risk (SDV01, CR01 or CS01). Provide the change in value of the portfolio resulting from a 1 basis point change in credit spreads where the shift is applied to the option adjusted spread, aggregated by investment grade and non-investment grade exposures, for each of the following maturities: 3 month, 1 year, 5 years, 10 years, and 30 years.

Investment grade.
Maturity period.
3 month.
1 year.
5 years.
10 years.
30 years.
Non-Investment grade.
Maturity period.
3 month.
1 year.
5 years.
10 years.
30 years.

For purposes of Item B.3., calculate value as the sum of the absolute values of:
(i) the value of each debt security,
(ii) the notional value of each swap, including, but not limited to, total return swaps, interest rate swaps, and credit default swaps, for which the underlying reference asset or assets are debt securities or an interest rate;
(iii) the notional value of each futures contract for which the underlying reference asset or assets are debt securities or an interest rate; and
(iv) the delta-adjusted notional value of any option for which the underlying reference asset is an asset described in clause (i),(ii), or (iii).

Report zero for maturities to which the Fund has no exposure. For exposures that fall between any of the listed maturities in (a) and (b), use linear interpolation to approximate exposure to each maturity listed above. For exposures outside of the range of maturities listed above, include those exposures in the nearest maturity.


Item B.4. Securities lending.

a. For each borrower in any securities lending transaction, provide the following information:

b. Did any securities lending counterparty provide any non-cash collateral? Yes No

Item B.5. Return information.

a. Monthly total returns of the Fund for each of the preceding three months. If the Fund is a Multiple Class Fund, report returns for each class. Such returns shall be calculated in accordance with the methodologies outlined in Item 26(b) (1) of Form N-1A, Instruction 13 to sub-Item 1 of Item 4 of Form N-2, or Item 26(b) (i) of Form N-3, as applicable.

Monthly Total Return Record: 1
Monthly total returns of the Fund for each of the preceding three months - Month 1.
Monthly total returns of the Fund for each of the preceding three months - Month 2.
Monthly total returns of the Fund for each of the preceding three months - Month 3.
b. Class identification number(s) (if any) of the Class(es) for which returns are reported.

c. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to derivatives for each of the following categories: commodity contracts, credit contracts, equity contracts, foreign exchange contracts, interest rate contracts, and other contracts. Within each such asset category, further report the same information for each of the following types of derivatives instrument: forward, future, option, swaption, swap, warrant, and other. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.

Asset category.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Asset category.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Asset category.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Asset category.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Asset category.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Asset category.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3
Instrument type.
Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3

d. For each of the preceding three months, monthly net realized gain (loss) and net change in unrealized appreciation (or depreciation) attributable to investment other than derivatives. Report in U.S. dollars. Losses and depreciation shall be reported as negative numbers.
Month 1


Monthly net realized gain(loss) - Month 1
Monthly net change in unrealized appreciation (or depreciation) - Month 1
Month 2
Monthly net realized gain(loss) - Month 2
Monthly net change in unrealized appreciation (or depreciation) - Month 2
Month 3
Monthly net realized gain(loss) - Month 3
Monthly net change in unrealized appreciation (or depreciation) - Month 3

Item B.6. Flow information.

Provide the aggregate dollar amounts for sales and redemptions/repurchases of Fund shares during each of the preceding three months. If shares of the Fund are held in omnibus accounts, for purposes of calculating the Fund's sales, redemptions, and repurchases, use net sales or redemptions/repurchases from such omnibus accounts. The amounts to be reported under this Item should be after any front-end sales load has been deducted and before any deferred or contingent deferred sales load or charge has been deducted. Shares sold shall include shares sold by the Fund to a registered unit investment trust. For mergers and other acquisitions, include in the value of shares sold any transaction in which the Fund acquired the assets of another investment company or of a personal holding company in exchange for its own shares. For liquidations, include in the value of shares redeemed any transaction in which the Fund liquidated all or part of its assets. Exchanges are defined as the redemption or repurchase of shares of one Fund or series and the investment of all or part of the proceeds in shares of another Fund or series in the same family of investment companies.
Month 1
a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
c. Total net asset value of shares redeemed or repurchased, including exchanges.
Month 2
a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
c. Total net asset value of shares redeemed or repurchased, including exchanges.
Month 3
a. Total net asset value of shares sold (including exchanges but excluding reinvestment of dividends and distributions).
b. Total net asset value of shares sold in connection with reinvestments of dividends and distributions.
c. Total net asset value of shares redeemed or repurchased, including exchanges.

Item B.7. Highly Liquid Investment Minimum information.

a. If applicable, provide the Fund's current Highly Liquid Investment Minimum.
b. If applicable, provide the number of days that the Fund's holdings in Highly Liquid Investments fell below the Fund's Highly Liquid Investment Minimum during the reporting period.
c. Did the Fund's Highly Liquid Investment Minimum change during the reporting period? Yes No N/A

Item B.8. Derivatives Transactions.

For portfolio investments of open-end management investment companies, provide the percentage of the Fund's Highly Liquid Investments that it has pledged as margin or collateral in connection with derivatives transactions that are classified among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]:

(1) Moderately Liquid Investments
(2) Less Liquid Investments
(3) Illiquid Investments

For purposes of Item B.8, when computing the required percentage, the denominator should only include assets (and exclude liabilities) that are categorized by the Fund as Highly Liquid Investments.

Classification

Item B.9. Derivatives Exposure for limited derivatives users.

If the Fund is excepted from the rule 18f-4 [17 CFR 270.18f-4] program requirement and limit on fund leverage risk under rule 18f-4(c)(4) [17 CFR 270.18f-4(c)(4)], provide the following information:

a. Derivatives exposure (as defined in rule 18f-4(a) [17 CFR 270.18f-4(a)]), reported as a percentage of the Fund's net asset value.
b. Exposure from currency derivatives that hedge currency risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
c. Exposure from interest rate derivatives that hedge interest rate risks, as provided in rule 18f-4(c)(4)(i)(B) [17 CFR 270.18f-4(c)(4)(i)(B)], reported as a percentage of the Fund's net asset value.
d. The number of business days, if any, in excess of the five-business-day period described in rule 18f-4(c)(4)(ii) [17 CFR 270.18f-4(c)(4)(ii)], that the Fund's derivatives exposure exceeded 10 percent of its net assets during the reporting period.

Item B.10. VaR information.

For Funds subject to the limit on fund leverage risk described in rule 18f-4(c)(2) [17 CFR 270.18f-4(c)(2)], provide the following information, as determined in accordance with the requirement under rule 18f-4(c)(2)(ii) to determine the fund's compliance with the applicable VaR test at least once each business day:

a. Median daily VaR during the reporting period, reported as a percentage of the Fund's net asset value.
b. For Funds that were subject to the Relative VaR Test during the reporting period, provide:
i. As applicable, the name of the Fund's Designated Index, or a statement that the Fund's Designated Reference Portfolio is the Fund's Securities Portfolio.
ii. As applicable, the index identifier for the Fund's Designated Index.
iii. Median VaR Ratio during the reporting period, reported as a percentage of the VaRof the Fund's Designated Reference Portfolio.
c. Backtesting Results. Number of exceptions that the Fund identified as a result of its backtesting of its VaR calculation model (as described in rule 18f-4(c)(1)(iv) [17 CFR 270.18f-4(c)(1)(iv)] during the reporting period.

NPORT-P: Part C: Schedule of Portfolio Investments

For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

Item C.1. Identification of investment.

a. Name of issuer (if any).
b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
c. Title of the issue or description of the investment.
d. CUSIP (if any).

At least one of the following other identifiers:

Identifier.
ISIN
Identifier.
Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
Description of other unique identifier.

Item C.2. Amount of each investment.

Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

Balance
Units
Description of other units.
Currency. Indicate the currency in which the investment is denominated.
Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
Exchange rate.
Percentage value compared to net assets of the Fund.

Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

Payoff profile. Long Short N/A

Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If "other," provide a brief description.
Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If "other", provide a brief description.

Item C.5. Country of investment or issuer.

Report the ISO country code that corresponds to the country where the issuer is organized.
If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.

Item C.6. Is the investment a Restricted Security?

Is the investment a Restricted Security? Yes No

Item C.7.

a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

i. Highly Liquid Investments
ii. Moderately Liquid Investments
iii. Less Liquid Investments
iv. Illiquid Investments
Category.

b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 2 3 N/A

Item C.9. For debt securities

For debt securities, also provide:

a. Maturity date.

b. Coupon.

i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
ii. Annualized rate.
c. Currently in default? [Y/N] Yes No
d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes No
e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes No

f. For convertible securities, also provide:

i. Mandatory convertible? [Y/N] Yes No
ii. Contingent convertible? [Y/N] Yes No

iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
If other identifier provided, indicate the type of identifier used.

v. Delta (if applicable).

Item C.10. For repurchase and reverse repurchase agreements, also provide:

a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase Reverse repurchase

b. Counterparty.

i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes No

ii. If N, provide the name and LEI (if any) of counterparty.

c. Tri-party? Yes No
d. Repurchase rate.
e. Maturity date.

f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

Item C.11. For derivatives, also provide:

Item C.12. Securities lending.

a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes No
b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes No
c. Is any portion of this investment on loan by the Fund? Yes No

NPORT-P: Part C: Schedule of Portfolio Investments

For each investment held by the Fund and its consolidated subsidiaries, disclose the information requested in Part C. A Fund may report information for securities in an aggregate amount not exceeding five percent of its total assets as miscellaneous securities in Part D in lieu of reporting those securities in Part C, provided that the securities so listed are not restricted, have been held for not more than one year prior to the end of the reporting period covered by this report, and have not been previously reported by name to the shareholders of the Fund or to any exchange, or set forth in any registration statement, application, or report to shareholders or otherwise made available to the public.

Item C.1. Identification of investment.

a. Name of issuer (if any).
b. LEI (if any) of issuer. In the case of a holding in a fund that is a series of a series trust, report the LEI of the series.
c. Title of the issue or description of the investment.
d. CUSIP (if any).

At least one of the following other identifiers:

Identifier.
ISIN
Identifier.
Other unique identifier (if ticker and ISIN are not available). Indicate the type of identifier used
Description of other unique identifier.

Item C.2. Amount of each investment.

Balance. Indicate whether amount is expressed in number of shares, principal amount, or other units. For derivatives contracts, as applicable, provide the number of contracts.

Balance
Units
Description of other units.
Currency. Indicate the currency in which the investment is denominated.
Value. Report values in U.S. dollars. If currency of investment is not denominated in U.S. dollars, provide the exchange rate used to calculate value.
Exchange rate.
Percentage value compared to net assets of the Fund.

Item C.3. Indicate payoff profile among the following categories (long, short, N/A). For derivatives, respond N/A to this Item and respond to the relevant payoff profile question in Item C.11.

Payoff profile. Long Short N/A

Item C.4. Asset and issuer type. Select the category that most closely identifies the instrument among each of the following:

Asset type (short-term investment vehicle (e.g., money market fund, liquidity pool, or other cash management vehicle), repurchase agreement, equity-common, equity-preferred, debt, derivative-commodity, derivative-credit, derivative-equity, derivative-foreign exchange, derivative-interest rate, derivatives-other, structured note, loan, ABS-mortgage backed security, ABS-asset backed commercial paper, ABS-collateralized bond/debt obligation, ABS-other, commodity, real estate, other). If "other," provide a brief description.
Issuer type (corporate, U.S. Treasury, U.S. government agency, U.S. government sponsored entity, municipal, non-U.S. sovereign, private fund, registered fund, other). If "other", provide a brief description.

Item C.5. Country of investment or issuer.

Report the ISO country code that corresponds to the country where the issuer is organized.
If different from the country where the issuer is organized, also report the ISO country code that corresponds to the country of investment or issuer based on the concentrations of the risk and economic exposure of the investments.

Item C.6. Is the investment a Restricted Security?

Is the investment a Restricted Security? Yes No

Item C.7.

a. Liquidity classification information. For portfolio investments of open-end management investment companies, provide the liquidity classification(s) for each portfolio investment among the following categories as specified in rule 22e-4 [17 CFR 270.22e-4]. For portfolio investments with multiple liquidity classifications, indicate the percentage amount attributable to each classification.

i. Highly Liquid Investments
ii. Moderately Liquid Investments
iii. Less Liquid Investments
iv. Illiquid Investments
Category.

b. If attributing multiple classification categories to the holding, indicate which of the three circumstances listed in the Instructions to Item C.7 is applicable.

Instructions to Item C.7 Funds may choose to indicate the percentage amount of a holding attributable to multiple classification categories only in the following circumstances: (1) if portions of the position have differing liquidity features that justify treating the portions separately; (2) if a fund has multiple sub-advisers with differing liquidity views; or (3) if the fund chooses to classify the position through evaluation of how long it would take to liquidate the entire position (rather than basing it on the sizes it would reasonably anticipated trading). In (1) and (2), a fund would classify using the reasonably anticipated trade size for each portion of the position.

Item C.8. Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles (ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient).

Indicate the level within the fair value hierarchy in which the fair value measurements fall pursuant to U.S. Generally Accepted Accounting Principles 7(ASC 820, Fair Value Measurement). [1/2/3] Report "N/A" if the investment does not have a level associated with it (i.e., net asset value used as the practical expedient). 1 2 3 N/A

Item C.9. For debt securities

For debt securities, also provide:

a. Maturity date.

b. Coupon.

i. Select the category that most closely reflects the coupon type among the following (fixed, floating, variable, none).
ii. Annualized rate.
c. Currently in default? [Y/N] Yes No
d. Are there any interest payments in arrears or have any coupon payments been legally deferred by the issuer? [Y/N] Yes No
e. Is any portion of the interest paid in kind? [Y/N] Enter "N" if the interest may be paid in kind but is not actually paid in kind or if the Fund has the option of electing in-kind payment and has elected to be paid in-kind. Yes No

f. For convertible securities, also provide:

i. Mandatory convertible? [Y/N] Yes No
ii. Contingent convertible? [Y/N] Yes No

iii. Description of the reference instrument, including the name of issuer, title of issue, and currency in which denominated, as well as CUSIP of reference instrument, ISIN (if CUSIP is not available), ticker (if CUSIP and ISIN are not available), or other identifier (if CUSIP, ISIN, and ticker are not available).
If other identifier provided, indicate the type of identifier used.

v. Delta (if applicable).

Item C.10. For repurchase and reverse repurchase agreements, also provide:

a. Select the category that reflects the transaction (repurchase, reverse repurchase). Select "repurchase agreement" if the Fund is the cash lender and receives collateral. Select "reverse repurchase agreement" if the Fund is the cash borrower and posts collateral. Repurchase Reverse repurchase

b. Counterparty.

i. Cleared by central counterparty? [Y/N] If Y, provide the name of the central counterparty. Yes No

ii. If N, provide the name and LEI (if any) of counterparty.

c. Tri-party? Yes No
d. Repurchase rate.
e. Maturity date.

f. Provide the following information concerning the securities subject to the repurchase agreement (i.e., collateral). If multiple securities of an issuer are subject to the repurchase agreement, those securities may be aggregated in responding to Items C.10.f.i-iii.

Item C.11. For derivatives, also provide:

Item C.12. Securities lending.

a. Does any amount of this investment represent reinvestment of cash collateral received for loaned securities? Yes No
b. Does any portion of this investment represent that is treated as a Fund asset and received for loaned securities? Yes No
c. Is any portion of this investment on loan by the Fund? Yes No

NPORT-P: Part E: Explanatory Notes (if any)

The Fund may provide any information it believes would be helpful in understanding the information reported in response to any Item of this Form. The Fund may also explain any assumptions that it made in responding to any Item of this Form. To the extent responses relate to a particular Item, provide the Item number(s), as applicable.
Note Item
Explanatory Notes

NPORT-P: Signatures

The Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Registrant:
By(Signature):
Name:
Title:
Date:

FAQ

What did USBF disclose in its latest NPORT-P filing?

The filing is largely blank; it contains no asset, liability, risk, or return data.

Does the NPORT-P show USBF's net asset value or portfolio holdings?

No. All financial fields are empty, so NAV and holdings are undisclosed.

Is this USBF's final NPORT-P report?

The form includes a question about final filing, but no answer was selected, so it is not marked as final.

Why is a blank NPORT-P significant to investors?

It provides no actionable information, hindering transparency and portfolio analysis.

What is Form NPORT-P used for?

It reports a fund’s monthly portfolio, risk metrics, and performance data to the SEC and investors.
iShares USD Systematic Bond ETF

NASDAQ:USBF

USBF Rankings

USBF Latest News

USBF Latest SEC Filings

USBF Stock Data

150.00k